Literature DB >> 22740386

Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?

Amanda Brown1, Raphael Hirsch, Tal Laor, Michael J Hannon, Marc C Levesque, Terence Starz, Kimberly Francis, C Kent Kwoh.   

Abstract

OBJECTIVE: Up to 90% of adults with rheumatoid arthritis (RA) in clinical remission have persistent synovitis and/or bone marrow lesions (BMLs) on magnetic resonance imaging (MRI). MRI findings in patients with juvenile idiopathic arthritis (JIA) in clinical remission have not been described. We utilized 3T MRI with contrast enhancement to examine JIA patients with hand and/or wrist involvement who were in clinical remission and compared them with a cohort of adult RA patients.
METHODS: In total, 11 JIA patients and 10 RA patients with arthritis involving the hands and/or wrists were identified by their primary rheumatologist as being in physician-defined clinical remission, having no signs or symptoms of active arthritis and no medication changes for at least 6 months. A study rheumatologist performed a joint evaluation for tenderness, swelling, and limitation of motion, and study participants self-reported tender joint counts. The participants underwent MRI with intravenous contrast enhancement of 1 hand and wrist with a history of prior symptoms. A pediatric musculoskeletal radiologist blinded to the clinical data scored the MRIs for synovitis, tenosynovitis, and/or BMLs.
RESULTS: Sixty-three percent of the JIA cohort and 70% of the RA cohort had MRI findings of synovitis, BMLs, and/or tenosynovitis. All pediatric patients with MRI abnormalities had normal physician tender and swollen joint counts. The patients' self-report of painful joint counts did not predict MRI abnormalities.
CONCLUSION: Over one-half of the patients in clinical remission had MRI evidence of persistent inflammation, defined as the presence of synovitis, tenosynovitis, or BMLs. A substantial portion of patients with JIA may have subclinical disease despite clinical remission.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22740386      PMCID: PMC4398346          DOI: 10.1002/acr.21774

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  43 in total

1.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Nicolino Ruperto; Edward Giannini
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

2.  Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.

Authors:  Richard J Wakefield; Jane E Freeston; Elizabeth M A Hensor; Domini Bryer; Mark A Quinn; Paul Emery
Journal:  Arthritis Rheum       Date:  2007-12-15

Review 3.  Current management of juvenile idiopathic arthritis.

Authors:  Carol A Wallace
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-04       Impact factor: 4.098

Review 4.  Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders.

Authors:  Patricia Woo
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

5.  Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Bin Huang; Marcia Bandeira; Angelo Ravelli; Edward H Giannini
Journal:  Arthritis Rheum       Date:  2005-11

6.  Magnetic resonance imaging identifies features in clinically unaffected knees predicting extension of arthritis in children with monoarthritis.

Authors:  Janet M Gardner-Medwin; Orla G Killeen; Clive A J Ryder; Karen Bradshaw; Karl Johnson
Journal:  J Rheumatol       Date:  2006-09-15       Impact factor: 4.666

7.  Remission status follow-up in children with juvenile idiopathic arthritis.

Authors:  Taciana A P Fernandes; José Eduardo Corrente; Claudia S Magalhães
Journal:  J Pediatr (Rio J)       Date:  2007-03-21       Impact factor: 2.197

8.  Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.

Authors:  A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2006-12

9.  Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Angelo Ravelli; Bin Huang; Edward H Giannini
Journal:  J Rheumatol       Date:  2006-02-15       Impact factor: 4.666

Review 10.  The Stanford Health Assessment Questionnaire: dimensions and practical applications.

Authors:  Bonnie Bruce; James F Fries
Journal:  Health Qual Life Outcomes       Date:  2003-06-09       Impact factor: 3.186

View more
  10 in total

Review 1.  Heading toward a modern imaging approach in juvenile idiopathic arthritis.

Authors:  Stefano Lanni; Alberto Martini; Clara Malattia
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

2.  Musculoskeletal ultrasound in children: Current state and future directions.

Authors:  Emily Brunner; Tracy Ting; Patricia Vega-Fernandez
Journal:  Eur J Rheumatol       Date:  2020-02

3.  [Remission in pediatric rheumatology].

Authors:  H-L Huppertz
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

Review 4.  Juvenile idiopathic arthritis - the role of imaging from a rheumatologist's perspective.

Authors:  Clara Malattia; Nikolay Tzaribachev; J Merlijn van den Berg; Silvia Magni-Manzoni
Journal:  Pediatr Radiol       Date:  2018-05-08

5.  Contrast-enhanced MRI compared with the physical examination in the evaluation of disease activity in juvenile idiopathic arthritis.

Authors:  Robert Hemke; Mario Maas; Mira van Veenendaal; Koert M Dolman; Marion A J van Rossum; J Merlijn van den Berg; Taco W Kuijpers
Journal:  Eur Radiol       Date:  2013-10-08       Impact factor: 5.315

6.  Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis.

Authors:  Robert Hemke; Taco W Kuijpers; Charlotte M Nusman; Dieneke Schonenberg-Meinema; Marion A J van Rossum; Koert M Dolman; J Merlijn van den Berg; Mario Maas
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

7.  Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee.

Authors:  E Charlotte van Gulik; Mendy M Welsink-Karssies; J Merlijn van den Berg; Dieneke Schonenberg-Meinema; Koert M Dolman; Anouk M Barendregt; Charlotte M Nusman; Mario Maas; Taco W Kuijpers; Robert Hemke
Journal:  Pediatr Radiol       Date:  2018-01-06

8.  Sequence-Specific Detection of Unlabeled Nucleic Acid Biomarkers Using a "One-Pot" 3D Molecular Sensor.

Authors:  Sameen Yousaf; Patrick J S King; Aline F Miller; Alberto Saiani; David J Clarke; Linda T Trivoluzzi; Harmesh S Aojula; Elena V Bichenkova
Journal:  Anal Chem       Date:  2019-07-11       Impact factor: 6.986

Review 9.  Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis.

Authors:  Varvara Choida; Margaret Hall-Craggs; Bethany R Jebson; Corinne Fisher; Maria Leandro; Lucy R Wedderburn; Coziana Ciurtin
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

10.  Contrast-enhanced MRI findings of the knee in healthy children; establishing normal values.

Authors:  Robert Hemke; J Merlijn van den Berg; Charlotte M Nusman; E Charlotte van Gulik; Anouk M Barendregt; Dieneke Schonenberg-Meinema; Koert M Dolman; Taco W Kuijpers; Mario Maas
Journal:  Eur Radiol       Date:  2017-10-06       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.